Day: September 26, 2016

EMCORE Expanding Production of Breakthrough Linear Externally Modulated Laser (L-EML™)-Based Transmitters

L-EMLTM-Based Transmitters Achieve Qualification and are Shipping to Major Cable MSOs                                                                    ALHAMBRA, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) — EMCORE Corporation (NASDAQ:EMKR), a leading provider of Indium Phosphide (InP) optical chips, components, subsystems and systems for the broadband and specialty fiber optics market, announced today that it is expanding production of DOCSIS 3.1, 1550 nm CATV transmitters utilizing Linear Externally Modulated Laser (L-EMLTM) technology. L-EMLTM-based transmitters have

Synacor Strengthens Sales Leadership, Appoints Timothy Schermerhorn as SVP, Service Provider Sales & Marketing

BUFFALO, N.Y., Sept. 26, 2016 (GLOBE NEWSWIRE) — Synacor, Inc. (Nasdaq:SYNC), the trusted multiscreen technology and monetization partner for video, internet and communications providers, device manufacturers and enterprises, today announced the appointment of Timothy Schermerhorn as Senior Vice President of Service Provider Sales and Marketing.   He will be responsible for all aspects of Synacor’s revenue efforts in the service provider market.  His addition strengthens Synacor’s sales leadership as the company looks to extend its broad product platform which is at the center of today’s most powerful digital trends including advertising, multiplatform video and messaging into new customers, verticals and geographies.

Red Lion Hotel Anaheim Resort Announces Discounts for a Magical Vacation

ANAHEIM, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) — RLHC (Red Lion Hotels Corporation) (NYSE:RLH) is welcoming fall and families from across the country to Red Lion Hotel Anaheim Resort to experience “the happiest place on earth” with a series of magically designed packages for kids of all ages visiting the Disneyland® Resort. From Mickey’s Halloween Party to Disney California Adventure® Park, Red Lion Hotel Anaheim Resort offers the ideal location to maximize the Disneyland® Resort experience. The 308 modern guest room hotel is located in walking distance to Disneyland® Resort’s main gate and offers onsite dining in the recently renovated

Condor Hospitality Trust Announces Sale of Non-Core Legacy Hotel

BETHESDA, Md., Sept. 26, 2016 (GLOBE NEWSWIRE) — Condor Hospitality Trust, Inc. (NASDAQ:CDOR), a hotel-focused real estate investment trust (REIT) headquartered and incorporated in the state of Maryland, today announced the closing on the sale of a legacy asset, the 81-room Super 8 located at 1622 North Broadway, Menomonie, WI for $3.0 million.  The net proceeds from the sale will be used for general corporate purposes and for future acquisitions of hotels that meet the Company’s new investment strategy.                                                                                                        “Year to date, Condor has sold 15 legacy hotels generating $34.6 million in gross proceeds,” said Bill Blackham, Condor’s Chief Executive

Applied Optoelectronics Demonstrates New Innovative Technologies at SCTE

SUGAR LAND, Texas, Sept. 26, 2016 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, will be showcasing its newest CATV products in a live demonstration of its FPGA-based remote PHY solution designed for next-generation distributed cable TV networks. The demonstration will be running throughout the SCTE/ISBE Cable-Tec Expo on Sept. 26-29 in Philadelphia, PA at booth #1619.  AOI’s technical expertise in both advanced optics and radio frequency design have been combined to produce this new remote PHY product that features the latest FPGA

Skkynet’s SkkyHub Powers Becker Mining Demo at MINExpo 2016

Mississauga, Ontario, Sept. 26, 2016 (GLOBE NEWSWIRE) — Skkynet Cloud Systems, Inc. (“Skkynet”) (OTCQB: SKKY), a global leader in real-time cloud information systems, announces that its SkkyHub™  technology is being used to provide real-time, remote data displays for a Becker Varis SSFM-100 smartsense® Atmospheric and Environmental System demonstration at MINExpo 2016 in Las Vegas, Nevada.  Show participants will be able to view live data from the SSFM-100 on a display monitor, as well as securely from their mobile phone browsers over their own cellular connection, in real time. The SSFM-100 smartsense® monitor provides a lighted display on the sensor itself

Feature Box

Internet Telephony Magazine Names Mitel Collaboration Solution a Lab Innovation Award Winner

[tweetshare tweet=”Jon Brinton of Mitel – Knowledge workers, information workers and services workers at businesses of all sizes, are seeking greater speed and simplicity in how they communicate and collaborate—in the office and on the go,.” username=”StockGuruDotCom”] OTTAWA, Sept. 26, 2016 (GLOBE NEWSWIRE) —   Brings speed and simplicity to how people communicate and collaborate Purpose-built for the modern teamwork environment and a mobile-first world Integrates seamlessly with more than 50 leading SaaS platforms   Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in real-time business, cloud and mobile communications, announced today that Internet Telephony Magazine has presented the company with a

Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months

PORTLAND, Ore., Sept. 26, 2016 (GLOBE NEWSWIRE) — Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported better-than-expected preliminary results in the Company’s chronic kidney disease study being conducted on the island of Bonaire. Statistical analysis of the preliminary study results indicates, at a 95 percent confidence level, that three out of four consumers could reasonably expect a ten per cent increase in filtration rate. Dr. Hausman stated, “Our preliminary results exceeded our expectations and represent new hope for patients facing the challenge of stage 2,3, or 4 CKD.” The data, analyzed by

Skyline Medical, Electronic On-Ramp and GLG Pharma Senior Management to be Interviewed on WPSL AM 1590

MINNEAPOLIS, Sept. 26, 2016 (GLOBE NEWSWIRE) — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that Dr. Carl Schwartz, Interim Chief Executive Officer of Skyline Medical; Bob Beringer, Chief Executive Officer of Electronic On-Ramp; and Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma, LLC. will be interviewed on WPSL’s “MONEYINFO by PRINCETON RESEARCH with MIKE KING and CHARLES MOSKOWITZ” show on Tuesday, September 27th.  The show will begin at 10:05 a.m. Eastern time and management’s interview will begin at 10:20 a.m. Management is expected to discuss recent

Gladstone Commercial Corporation Signs New Lease, Increasing Occupancy at Bolingbrook, Illinois Property to 100%

MCLEAN, Va., Sept. 26, 2016 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (NASDAQ:GOOD) (“Gladstone Commercial”) announced today that it has executed a new lease totaling 20,719 square feet on previously vacant space at its 55,480 square foot industrial property located in Bolingbrook, Illinois. The new lease expires in early 2024 and brings the property’s occupancy to 100% with no lease rollover until April 2022. The tenant operates and franchises businesses engaged in cleaning carpets, upholstery, and ventilation air ducts and in providing water mitigation and restoration services for businesses throughout the United States. Brandon Flickinger (Director, Real Estate, of Gladstone Commercial)

Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer

PALO ALTO, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) — Orbus Therapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases, today announced that the first patient has been enrolled in a pivotal Phase 3 clinical trial, called STELLAR, of eflornithine in patients with anaplastic astrocytoma whose cancer has recurred following radiation and adjuvant chemotherapy. Eflornithine is a novel cytostatic agent that the Company is developing to treat patients with recurrent anaplastic astrocytoma, a subtype of anaplastic glioma, a rare form of brain cancer. Eflornithine is designated as an orphan drug in

BioSig Technologies Sponsors The 11th International Symposium on Ventricular Arrhythmias

Minneapolis, MN, Sept. 26, 2016 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, today announced they have provided an unrestricted educational grant to The 11th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy hosted by The Mount Sinai Hospital in New York and the University of Pennsylvania Health System in Philadelphia to be held at the New York Hilton Midtown on October 7 and 8, 2016.  The course has been developed to meet the educational needs of electrophysiologists and other physicians with an

Cartesian Announces Listing Transfer to the Nasdaq Capital Market

OVERLAND PARK, Kan., Sept. 26, 2016 (GLOBE NEWSWIRE) — Cartesian™ (NASDAQ:CRTN), a leading provider of consulting services and managed solutions to the global telecom, media and technology industries, has received approval from the NASDAQ Stock Market (Nasdaq) of the Company’s request to transfer listing of its common stock to the Nasdaq Capital Market from the Nasdaq Global Market. As previously disclosed, Cartesian received a letter from Nasdaq on August 22, 2016 that it no longer satisfied the minimum stockholders’ equity requirement for continued listing on the Nasdaq Global Market. In order to satisfy the minimum stockholders’ equity requirement, the Company

Mateon Announces Collaboration with US Oncology Research to Participate in Phase 2/3 FOCUS Study

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (Nasdaq:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today announced a collaboration under which sites affiliated with US Oncology Research will participate in the FOCUS Study, Mateon’s recently initiated phase 2/3 clinical trial in platinum-resistant ovarian cancer. “We are pleased to work with US Oncology Research, an outstanding organization that has had tremendous success in oncology-related clinical trials,” stated William D. Schwieterman, M.D., President and Chief Executive Officer of Mateon. “US Oncology Research is selective regarding the studies in

Lipocine Announces Positive Top-Line Phase 2b Study Results for LPCN 1111, a Next Generation Oral Testosterone Replacement Therapy

Once-daily dose identified for the pivotal Phase 3 study Well tolerated with no drug-related severe or serious adverse events reported SALT LAKE CITY, Sept. 26, 2016 (GLOBE NEWSWIRE) — Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today reported positive top-line results from a Phase 2b clinical study of LPCN 1111, a novel oral testosterone replacement therapy (“TRT”) product candidate. The primary objectives of the study were to determine the Phase 3 dose of LPCN 1111 along with the safety and tolerability of LPCN 1111 and its metabolites following oral administration of single and multiple doses in hypogonadal males. The Phase

Skullcandy® Expands Sport Performance Line with Method® Wireless Earbuds

PARK CITY, Utah, Sept. 26, 2016 (GLOBE NEWSWIRE) — Skullcandy, Inc. (NASDAQ:SKUL), the performance and lifestyle audio brand founded at the intersection of music, sports, technology, and creative culture, is expanding its sports performance category with Method® Wireless, a Bluetooth® version of Method®, its best-selling sport earbud. “Our research shows that while the benefits of wireless are most obvious in the application of sport, many consumers still use their day-to-day earbuds. They report insufficient fit and durability, and as a result, are missing the potential for a better workout experience,” said Jeff Hutchings, Vice President of Product at Skullcandy. “Because

Hurco Technology Empowers Manufacturers at the International Manufacturing Technology Show

INDIANAPOLIS, Sept. 26, 2016 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq:HURC), showcased manufacturing technologies that solve the problems manufacturers confront each day at the International Manufacturing Technology Show (IMTS) in Chicago that took place from Sept. 12-17. IMTS was the first trade show that featured all three Hurco Companies, Inc., brands at one venue. In addition to the well-established Hurco brand of CNC machines, the brands of CNC machines that Hurco Companies purchased in 2015, Takumi and Milltronics, were exhibited at the 16,000-square-foot booth. IMTS was the official rollout of the Takumi brand in North America. The Takumi CNC machines


September 26, 2016 (Vancouver, Canada)… Lundin Gold Inc. (“Lundin Gold” or the “Company”) (TSX: “LUG”, Nasdaq Stockholm: “LUG”) announces that one of its significant shareholders, Kinross Gold Corporation, has agreed to sell and GMP Securities L.P. has agreed to purchase for re-sale to existing and institutional shareholders on a private placement basis, 5,500,000 common shares of the Company.  Upon closing of the transaction, Kinross will hold 20,656,250 shares, representing 17.4% of the issued and outstanding common shares of the Company. Closing of the transaction is subject to customary closing conditions including, but not limited to, the receipt of all necessary approvals, and

Feature Box

Xplore Receives Additional $1.1 Million Ultra-Rugged Tablet Order as Part of Ongoing U.S. Military Project

AUSTIN, Texas, Sept. 26, 2016 (GLOBE NEWSWIRE) — Xplore Technologies Corp. (NASDAQ:XPLR) today announced a $1.1 million follow-on order for customized XC6 M2 tablet computers. This order is the latest in a multi-year, multi-million-dollar mobility project begun with the United States military in 2012. With this most recent order, Xplore’s total revenue for this project stands at more than $10 million to date. Since 2012, the customer has purchased more than 3,000 customized Xplore XC6 Ultra-Rugged Tablet PCs. The XC6 M2 tablets are then deployed as the basis of the customer’s third-party OEM solution, which the U.S. military utilizes for

Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection

The companies have entered into an agreement and partnership to offer biotech and pharmaceutical companies access to ApoCell’s ApoStream™ technology for the detection, isolation and enrichment of rare and circulating tumor cells across a variety of cancers. CGI has immediate plans to provide the technology and associated downstream analysis and profiling for discovery, clinical trial and patient monitoring applications. Analysts expect the market opportunity for liquid biopsies to exceed $29 Billion for oncology indications.1 RUTHERFORD, N.J. and HOUSTON, Sept. 26, 2016 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through